Biotech pullback and RNN’s prospects
by westcoaster | March 26, 2014 2:54 pm
I’m still holding my position in RNN despite the drop over the past week. I know there are quite a few Irregulars who own this stock, and I’d be grateful for any thoughts on where they think RNN is heading. Nothing fundamental has changed at the company; I think it’s just getting clobbered by the general biotech carnage.
Source URL: https://www.stockgumshoe.com/2014/03/microblog-biotech-pullback-and-rnns-prospects/
Paul: I believe that you are absolutely correct in your comments. This seems like a buying opportunity to me. I may add shares to my existing position.
Thanks Stephen. RNN reports earnings in April, and we’ll have to wait until then, I think, for any real news. I’d add more too, but I’m overweight in it already.
Sorry, next earnings May 8.
RNN up .15 today! Hopefully, it will continue..
Press Release out today
http://investors.rexahn.com/releasedetail.cfm?ReleaseID=837198
Won Jun Choi et. al. Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity. Journal of Medicinal Chemistry. 2012 (55): 4521-4525
THIS IS A LINK THAT WILL REASSURE EARLY INVESTORS….
but the race is on and it looks as if “The Market” will crash before the clinical studies are completed.
So our dilemma is whether or not to buy or sell now…or wait…
i am long RNN.